Gliclazid-Mepha 30 retard
Gliclazid-Mepha 30 retard is a medicine authorised by Swissmedic under authorisation number 58504. The authorisation holder is Mepha Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 08 July 2008 and the authorisation is valid without a time limit. ATC code A10BB09 places the medicine in the group Drugs used in diabetes.
| Authorisation number | 58504 |
|---|---|
| Name | Gliclazid-Mepha 30 retard |
| Full name | Gliclazid-Mepha 30 retard, Depotabs |
| Authorisation holder | Mepha Pharma AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | A10BB09 |
| First authorisation | 08 July 2008 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Gliclazid-Mepha 30 retard, Depotabs | B | 08 July 2008 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 20 | Tablette(n) | A10BB09 | 07.06.2. | B |
| 2 | 30 | Tablette(n) | A10BB09 | 07.06.2. | B |
| 3 | 120 | Tablette(n) | A10BB09 | 07.06.2. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Gliclazid-Mepha 30 retard authorised in Switzerland?
Yes. Gliclazid-Mepha 30 retard is authorised by Swissmedic under authorisation number 58504, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Gliclazid-Mepha 30 retard have?
Gliclazid-Mepha 30 retard is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Gliclazid-Mepha 30 retard?
The authorisation holder is Mepha Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.